Anthony Molloy

CIK 1900012 · View on SEC EDGAR ↗

Insider

First SEC filing: Dec. 17, 2021 · Latest: Dec. 17, 2021

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 12 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

12 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 6, 2023 PCRX S 10b5-1 4,521 $38.55 $174,285 12,877 Direct -25.99% Disposed -37.5% (price as of 2026-08-20)
June 5, 2023 PCRX S 10b5-1 2,267 $38.28 $86,781 17,398 Direct -11.53% Disposed -37.1% (price as of 2026-08-20)
Jan. 5, 2023 PCRX S 10b5-1 546 $38.31 $20,917 19,450 Direct -2.73% Disposed -37.1% (price as of 2026-08-20)
Jan. 4, 2023 PCRX S 10b5-1 158 $39.09 $6,176 19,996 Direct -0.78% Disposed -38.4% (price as of 2026-08-20)
June 7, 2022 PCRX S 10b5-1 1,830 $60.40 $110,532 12,000 Direct -13.23% Disposed -60.1% (price as of 2026-08-20)
June 7, 2022 PCRX S 10b5-1 740 $59.38 $43,941 13,830 Direct -5.08% Disposed -59.4% (price as of 2026-08-20)
June 6, 2022 PCRX S 10b5-1 2,980 $61.37 $182,883 14,570 Direct -16.98% Disposed -60.8% (price as of 2026-08-20)
April 6, 2022 PCRX S 10b5-1 2,503 $77.94 $195,084 17,550 Direct -12.48% Disposed -69.1% (price as of 2026-08-20)
April 6, 2022 PCRX S 10b5-1 3,937 $77.03 $303,267 20,053 Direct -16.41% Disposed -68.7% (price as of 2026-08-20)
April 6, 2022 PCRX S 10b5-1 16,060 $76.03 $1,221,042 23,990 Direct -40.10% Disposed -68.3% (price as of 2026-08-20)
Jan. 18, 2022 PCRX S 10b5-1 224 $63.55 $14,235 17,550 Direct -1.26% Disposed -62.1% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 8, 2022 PCRX Stock Option (Right to Buy) Common Stock (19,900) $59.39 June 8, 2032 19,900 Acquired
April 6, 2022 PCRX Stock Option (Right to Buy) Common Stock (7,000) $38.35 June 13, 2028 7,000 Disposed
April 6, 2022 PCRX Stock Option (Right to Buy) Common Stock (2,500) $34.38 May 2, 2028 2,500 Disposed
April 6, 2022 PCRX Stock Option (Right to Buy) Common Stock (10,000) $44.20 June 14, 2027 10,000 Disposed
April 6, 2022 PCRX Stock Option (Right to Buy) Common Stock (3,000) $40.34 June 15, 2026 3,000 Disposed
Jan. 4, 2022 PCRX Stock Option (Right to Buy) Common Stock (5,000) $61.60 Jan. 4, 2032 5,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 13 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Dec. 17, 2021 PCRX Common Stock 15,550 Direct
Dec. 17, 2021 PCRX Stock Option (Right to Buy)→ Common Stock (15,000) 15,000 Direct
Dec. 17, 2021 PCRX Stock Option (Right to Buy)→ Common Stock (10,000) 10,000 Direct
Dec. 17, 2021 PCRX Stock Option (Right to Buy)→ Common Stock (22,000) 22,000 Direct
Dec. 17, 2021 PCRX Stock Option (Right to Buy)→ Common Stock (26,300) 26,300 Direct
Dec. 17, 2021 PCRX Stock Option (Right to Buy)→ Common Stock (8,750) 8,750 Direct
Dec. 17, 2021 PCRX Stock Option (Right to Buy)→ Common Stock (3,125) 3,125 Direct
Dec. 17, 2021 PCRX Stock Option (Right to Buy)→ Common Stock (10,000) 10,000 Direct
Dec. 17, 2021 PCRX Stock Option (Right to Buy)→ Common Stock (3,000) 3,000 Direct
Dec. 17, 2021 PCRX Stock Option (Right to Buy)→ Common Stock (4,000) 4,000 Direct
Dec. 17, 2021 PCRX Stock Option (Right to Buy)→ Common Stock (5,500) 5,500 Direct
Dec. 17, 2021 PCRX Stock Option (Right to Buy)→ Common Stock (5,000) 5,000 Direct
Dec. 17, 2021 PCRX Stock Option (Right to Buy)→ Common Stock (12,500) 12,500 Direct